Clinical Trials Browser

Terminated × Solid Tumors, KRAS Mutation × Clear all

NCT04835714 2023-02-01

A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Phase 1 Terminated

Other solid neoplasm

Solid Tumors, KRAS Mutation